维普中文期刊产品整合服务
931篇 您的检索式:作者名="YEO H"
    题名 作者 年代 出处 被引量
1具有低动脉粥样硬化风险特征的专业耐力运动员的亚临床冠状动脉疾病发病率显示文摘研究表明,具有冠状动脉疾病(coronary artery disease,CAD)危险因素的中老年(健将)运动员比久坐个体冠状动脉钙化(coronary artery calcium,CAC)评分更高。尚没有研究评估具有低动脉粥样硬化风险特征的专业运动员的CAD患病率。刘莉 叶鹏 Merghani A Maestrini V Rosmini S Cox AT Dhutia H Bastiaenen R David S Yeo TJ Narain R Malhotra A Papadakis M Wilson MG Tome M AlFakih K Moon JC Sharma S 2017中华高血压杂志2017,25,6:8
2Comparison of renal safety of tenofovir and entecavir in patients with chronic hepatitis B: Systematic review with meta-analysis显示文摘BACKGROUND Recently, the American Association for the Study of Liver Disease suggested no preference between tenofovir(TDF) and entecavir(ETV) regarding potential long-term risks of renal complications. Over the years, renal safety has become a critical concern in nucleos(t)ide analog-treated patients due to the long-term use of these drugs. However, existing studies do not show significant differences in renal dysfunction between these two drugs. Further, there is a paucity of studies comparing the long-term renal effects of TDF and ETV.AIM To investigate the effects of TDF and ETV on renal function, we performed systematic review and meta-analysis.METHODS Two investigators independently searched the Cochrane Library, MEDLINE, and Embase databases for randomized controlled trials and nonrandomized studies(NRSs) using the keywords 'CHB', 'Tenofovir', and 'Entecavir', and additional references were obtained from the bibliographies of relevant articles published through December 2017. The quality of each study was assessed using the Newcastle-Ottawa scale and the Grading of Recommendations Assessment,Development and Evaluation criteria. The primary outcome was the change in serum creatinine level in the TDF and ETV groups at baseline, 6 mo, 12 mo and24 mo.RESULTSNine NRSs comprising 2263 participants met the inclusion criteria. Changes in creatinine levels were higher in the TDF group than in the ETV group at 6 mo[mean difference(MD) = 0.03 mg/dL;95%CI: 0.02-0.04;I2 = 0%], 12 mo(MD =0.05 mg/dL;95%CI: 0.02-0.08;I2 = 78%), and 24 mo(MD = 0.07 mg/dL;95%CI:0.01-0.13;I2 = 93%). The change in estimated glomerular filtration rate(eGFR) was significantly higher in the TDF group than in the ETV group at 6 mo[standardized mean difference(SMD),-0.22;95%Cl:-0.36--0.08;I2 = 0%], 12 mo(SMD =-0.24;95%Cl:-0.43--0.05;I2 = 50%), and 24 mo(-0.35;95%Cl:-0.61--0.09;I2= 67%).CONCLUSION TDF statistically significantly increased serum creatinine levels and decreased the eGFR in 6-24 mo compared to ETV, with moderate to low quality of evidence.However, the differences are negligible.Hyo-Young Lee Hyunwoo Oh Chan-Hyuk Park Yee-Hui Yeo Mindie H Nguyen Dae-Won Jun 2019World Journal of Gastroenterology2019,25,23:6
3在全球无干扰素的DAA治疗方案与HCV相关HCC患者生存率增加有关显示文摘【据《Hepatology》2019年10月报道】题:在全球无干扰素的DAA治疗方案与HCV相关的HCC患者生存率增加有关(作者Dang H等)亚洲和西方国家使用无干扰素(IFN)的直接抗病毒药物(DAA)治疗方案后,实现持续病毒学应答(SVR)的HCV相关HCC患者的生存数据有限。该研究比较未接受HCV治疗的HCV相关HCC患者和获得SVR的患者的生存率。其运用2005-2017年间来自美国的2个中心和亚洲的6个中心的数据,研究将1676例仅感染HCV相关的HCC患者分为未经HCV治疗的患者(未治疗组)和DAA治疗的SVR患者(SVR组),并通过倾向评分匹配(PSM)进行分配;将HCV治疗状态作为时变协变量的多元Cox回归分析模型用于确定死亡风险和界标分析以避免永恒的时间偏移。该研究有1239例未经HCV治疗和437例SVR患者。经PSM后321对配对患者的背景风险平衡(P值均>0.05)。张建丽 DANG H YEO YH YASUDA S 2020临床肝胆病杂志2020,36,1:5
4Pancreatic cancer显示文摘Theresa Pluth Yeo Ralph H Hruban Steven D Leach Robb E Wilentz Taylor A Sohn Scott E Kern Christine A Iacobuzio-Donahue Anirban Maitra Michael Goggins Marcia I Canto Ross A Abrams Daniel Laheru Elizabeth M Jaffee Manuel Hidalgo Charles J Yeo 2002Current Problems in Cancer2002,,4:2
5Fermi pinninginduced thermal instability of metal-gate work function 显示文摘YU H Y REN C YEO Y C 2004IEEE Elec Dev Lett2004,25,5:1
6Imaging of a moving target with rotating parts based on the hough transform显示文摘ZHANG Qun YEO T S TAN H S 2008IEEE Transactions on Geoscience and Re- mote Sensing2008,46,1:1
7A fast procedure for computing incremental growth distances显示文摘Hong S M Yeo J H Park H W 2000Robotics2000,18,4:1
8Exosomes:a new delivery system for tumor antigens in cancer immunotherapy显示文摘CHO J A YEO D J SON H Y 2005Int J Cancer2005,114,4:1
9Imaging of a moving target with rotating parts based on the Hough transform显示文摘ZHANG Q YEO T S TAN H S 2008IEEE Transactions on Geoscience and Remote Sensing2008,46,1:1
10The effects of Pva/chitosan/fibroin (PCF)-blended spongy sheets on wound healing in rats 显示文摘YEO J H LEE K G KIM H C 2000Biol Pharm Bull2000,23,10:1
11Non-puerperal uterine inver-siona case report显示文摘LaiF M Tseng P Yeo S H 1993Singpore Med J1993,34,5:1
12Laboratory evaluation of temperature effects on the germination and growth of entomopathogenic fungi and on their pathogenicity to two aphid species显示文摘Yeo H Pell J K Alderson P G Clark S J Pye B J 2003Pest Manage Sci2003,59,:1
13A finite element model for 2-dimensional slice of cast strand显示文摘Han H N Lee J E Yeo T J 1999ISIJ Int1999,39,5:1
14Integrating supply chain and critical chain concepts in engineer-procure-construct ( EPC ) projects 显示文摘Yeo K T Ning J H 2002International Journal of Project Management2002,20,4:1
15Therapeutic drug concentrations of teicoplanin in clinical settings显示文摘Nah S Y Im J H Yeo J Y 2014Infect Chemother2014,46,1:1
16Loss of transgelin in repeated bouts of ulcerative colitis induced colon carcinogenesis显示文摘Yeo M Kim D K Park H J et aI 2006Proteomics2006,6,4:1
17Electro-thermal modeling of anode and cathode in micro-EDM 显示文摘Yeo S H Kurnia W Tan P C 2007Phys D: Appl Phys2007,40,:1
18A study on the control of water flow and temperature in the radiant cooling system through simulations 显示文摘Kim Y Y Lim J H Yeo M S 2001Korean Journal of Air-Conditioning and Refrigeration Engineering2001,13,6:1
19Astroglial loss and edema formation in the rat piriform cortex and hippocampus follo- wing pilocarpine-induced status epilepticus显示文摘KIM J E YEO S I RYU H J 2010J Comp Neu- rol2010,518,22:1
20Crystal formation of BaCl2 and NH4Cl using a supercritical fluid antisolvent 显示文摘YEO S D CHOI J H LEE T J 2000Journal of Supercritical Fluids2000,16,:1
返回顶部 每页显示:
共47页 首页 上一页 第1页 下一页 末页 /47 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费